Cargando…

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

Highly sensitive and specific plasma biomarkers for Alzheimer’s disease (AD) have the potential to improve diagnostic accuracy in the clinic and facilitate research studies including enrollment in prevention and treatment trials. We recently reported CSF tau hyperphosphorylation, especially on T217,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barthélemy, Nicolas R., Horie, Kanta, Sato, Chihiro, Bateman, Randall J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2020
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596823/ https://www.ncbi.nlm.nih.gov/pubmed/32725127 http://dx.doi.org/10.1084/jem.20200861

Ejemplares similares

Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
por: Horie, Kanta, et al.
Publicado: (2020)

Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2019)

Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios
por: Janelidze, Shorena, et al.
Publicado: (2023)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling
por: Pitson, Stuart M., et al.
Publicado: (2005)

Isoform specificity of progesterone receptor antibodies
por: Fabris, Victoria, et al.
Publicado: (2017)

Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration
por: Ishida, Kazuhisa, et al.
Publicado: (2022)

Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury
por: Gadani, Sachin P., et al.
Publicado: (2017)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Sato, Chihiro, et al.
Publicado: (2021)

Age-related alterations in meningeal immunity drive impaired CNS lymphatic drainage
por: Rustenhoven, Justin, et al.
Publicado: (2023)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
por: Barthélemy, Nicolas R., et al.
Publicado: (2020)

Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
por: Schulze-Topphoff, Ulf, et al.
Publicado: (2013)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Neuronal activity regulates extracellular tau in vivo
por: Yamada, Kaoru, et al.
Publicado: (2014)

Follicular Dendritic Cells Specifically Express the Long CR2/CD21 Isoform
por: Liu, Yong-Jun, et al.
Publicado: (1997)

Activated microglia mitigate Aβ-associated tau seeding and spreading
por: Gratuze, Maud, et al.
Publicado: (2021)

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
por: Soler, Adriana, et al.
Publicado: (2013)

The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity
por: Klotz, Luisa, et al.
Publicado: (2009)

Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction
por: Ezerskiy, Lubov A., et al.
Publicado: (2022)

Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
por: Jain, Nimansha, et al.
Publicado: (2022)

IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
por: Kroenke, Mark A., et al.
Publicado: (2008)

Human Cd1b and Cd1c Isoforms Survey Different Intracellular Compartments for the Presentation of Microbial Lipid Antigens
por: Briken, Volker, et al.
Publicado: (2000)

An Apoptosis-inducing Isoform of Neu Differentiation Factor (NDF) Identified Using a Novel Screen for Dominant, Apoptosis-inducing Genes
por: Grimm, Stefan, et al.
Publicado: (1997)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Role of Tyrosine Phosphorylation of HS1 in B Cell Antigen Receptor-mediated Apoptosis
por: Yamanashi, Yuji, et al.
Publicado: (1997)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
por: Loot, Annemarieke E., et al.
Publicado: (2009)

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease
por: Salvadó, Gemma, et al.
Publicado: (2023)

SLP-65: A New Signaling Component in B Lymphocytes which Requires Expression of the Antigen Receptor for Phosphorylation
por: Wienands, Jürgen, et al.
Publicado: (1998)

NLRC4 inflammasome activation is NLRP3- and phosphorylation-independent during infection and does not protect from melanoma
por: Tenthorey, Jeannette L., et al.
Publicado: (2020)

Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease
por: Roh, Jee Hoon, et al.
Publicado: (2014)

G-CSF rescues the memory impairment of animal models of Alzheimer's disease
por: Tsai, Kuen-Jer, et al.
Publicado: (2007)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
por: Janelidze, Shorena, et al.
Publicado: (2022)

Vav1 Phosphorylation Is Induced by β2 Integrin Engagement on Natural Killer Cells Upstream of Actin Cytoskeleton and Lipid Raft Reorganization
por: Riteau, Béatrice, et al.
Publicado: (2003)

Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates
por: Xu, Yulong, et al.
Publicado: (2020)

Molecular Cloning of the cDNA Encoding pp36, a Tyrosine-phosphorylated Adaptor Protein Selectively Expressed by T Cells and Natural Killer Cells
por: Weber, John R., et al.
Publicado: (1998)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mkqm1889c5es2o6d5qb6g5sjlc